发明名称 |
METHODS FOR ENHANCING THE EFFICACY OF VASCULAR DISRUPTING AGENTS |
摘要 |
This invention relates to methods for treating, preventing and/or managing cancer in a subject including enhacing the efficacy of a Vascular Disrupting Agent (e.g., a combretastatin or derivative thereof) by administering to the subject a Chemokine Receptor Angtagonist (e.g., a CXCR4 antagonist) or Chemokine Antagonist (e.g., a SDF- 1 antagonist) sequentially or simultaneously in combination with said Vascular Disrupting Agent. |
申请公布号 |
WO2008109076(A1) |
申请公布日期 |
2008.09.12 |
申请号 |
WO2008US02864 |
申请日期 |
2008.03.03 |
申请人 |
OXIGENE, INC.;KERBEL, ROBERT;SHAKED, YUVAL |
发明人 |
KERBEL, ROBERT;SHAKED, YUVAL |
分类号 |
A01N57/36;A61K31/66 |
主分类号 |
A01N57/36 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|